[Physiopathological significance of the phenomenon of proteolysis in post-burn shock].
D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology; D001798:Blood Proteins / Q000378:metabolism; D002056:Burns / Q000150:complications* / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000209:etiology; D006801:Humans; D007511:Ischemia / Q000209:etiology; D008659:Metabolic Diseases / Q000209:etiology*; D011506:Proteins / Q000378:metabolism*; D012774:Shock, Traumatic / Q000188:drug therapy / Q000503:physiopathology*; D014361:Trypsin Inhibitors / Q000627:therapeutic use
D001798:Blood Proteins; D011506:Proteins; D014361:Trypsin Inhibitors; D007611:Aprotinin
Semnificatia fiziopatologică a fenomenului de proteoliză în şocul postcombustional